vs

Side-by-side financial comparison of TOOTSIE ROLL INDUSTRIES INC (TR) and Zai Lab Ltd (ZLAB). Click either name above to swap in a different company.

TOOTSIE ROLL INDUSTRIES INC is the larger business by last-quarter revenue ($196.3M vs $127.1M, roughly 1.5× Zai Lab Ltd). On growth, Zai Lab Ltd posted the faster year-over-year revenue change (17.1% vs 1.5%). TOOTSIE ROLL INDUSTRIES INC produced more free cash flow last quarter ($61.0M vs $-26.7M). Over the past eight quarters, Zai Lab Ltd's revenue compounded faster (20.8% CAGR vs 13.2%).

Tootsie Roll Industries is an American manufacturer of confectionery based in Chicago, Illinois. Its best-known products include the namesake Tootsie Rolls and Tootsie Pops. Tootsie Roll Industries currently markets its brands internationally in Canada, Mexico, and over 75 other countries.

Zai Lab Ltd is a global biopharmaceutical company focused on developing, manufacturing and commercializing innovative therapies for oncology, autoimmune disorders, infectious diseases and other unmet medical needs. It operates primarily in the Greater China region and partners with leading global biotech firms to expand access to life-saving treatments for underserved patient populations.

TR vs ZLAB — Head-to-Head

Bigger by revenue
TR
TR
1.5× larger
TR
$196.3M
$127.1M
ZLAB
Growing faster (revenue YoY)
ZLAB
ZLAB
+15.6% gap
ZLAB
17.1%
1.5%
TR
More free cash flow
TR
TR
$87.7M more FCF
TR
$61.0M
$-26.7M
ZLAB
Faster 2-yr revenue CAGR
ZLAB
ZLAB
Annualised
ZLAB
20.8%
13.2%
TR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
TR
TR
ZLAB
ZLAB
Revenue
$196.3M
$127.1M
Net Profit
$28.8M
Gross Margin
35.7%
51.0%
Operating Margin
17.0%
-54.6%
Net Margin
14.7%
Revenue YoY
1.5%
17.1%
Net Profit YoY
27.9%
EPS (diluted)
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
TR
TR
ZLAB
ZLAB
Q4 25
$196.3M
$127.1M
Q3 25
$232.7M
$115.4M
Q2 25
$155.1M
$109.1M
Q1 25
$148.5M
$105.7M
Q4 24
$193.4M
$108.5M
Q3 24
$225.9M
$101.8M
Q2 24
$150.7M
$100.1M
Q1 24
$153.2M
$87.1M
Net Profit
TR
TR
ZLAB
ZLAB
Q4 25
$28.8M
Q3 25
$35.7M
$-36.0M
Q2 25
$17.5M
$-40.7M
Q1 25
$18.1M
$-48.4M
Q4 24
$22.5M
Q3 24
$32.8M
$-41.7M
Q2 24
$15.6M
$-80.3M
Q1 24
$15.8M
$-53.5M
Gross Margin
TR
TR
ZLAB
ZLAB
Q4 25
35.7%
51.0%
Q3 25
34.1%
59.5%
Q2 25
36.4%
60.6%
Q1 25
35.3%
63.6%
Q4 24
39.1%
61.5%
Q3 24
34.1%
64.1%
Q2 24
33.5%
64.9%
Q1 24
32.7%
61.4%
Operating Margin
TR
TR
ZLAB
ZLAB
Q4 25
17.0%
-54.6%
Q3 25
13.9%
-42.3%
Q2 25
7.8%
-50.3%
Q1 25
15.5%
-53.3%
Q4 24
20.0%
-62.6%
Q3 24
15.6%
-66.6%
Q2 24
10.2%
-76.0%
Q1 24
7.3%
-80.7%
Net Margin
TR
TR
ZLAB
ZLAB
Q4 25
14.7%
Q3 25
15.3%
-31.2%
Q2 25
11.3%
-37.3%
Q1 25
12.2%
-45.8%
Q4 24
11.6%
Q3 24
14.5%
-40.9%
Q2 24
10.4%
-80.2%
Q1 24
10.3%
-61.4%
EPS (diluted)
TR
TR
ZLAB
ZLAB
Q4 25
$-0.05
Q3 25
$-0.03
Q2 25
$-0.04
Q1 25
$-0.04
Q4 24
$-0.09
Q3 24
$-0.04
Q2 24
$-0.08
Q1 24
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
TR
TR
ZLAB
ZLAB
Cash + ST InvestmentsLiquidity on hand
$176.6M
$689.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$941.0M
$715.5M
Total Assets
$1.3B
$1.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
TR
TR
ZLAB
ZLAB
Q4 25
$176.6M
$689.6M
Q3 25
$119.8M
$717.2M
Q2 25
$170.5M
$732.2M
Q1 25
$176.6M
$757.3M
Q4 24
$194.6M
$779.7M
Q3 24
$163.2M
$616.1M
Q2 24
$131.2M
$630.0M
Q1 24
$159.4M
$650.8M
Stockholders' Equity
TR
TR
ZLAB
ZLAB
Q4 25
$941.0M
$715.5M
Q3 25
$918.9M
$759.9M
Q2 25
$893.1M
$791.7M
Q1 25
$879.4M
$810.8M
Q4 24
$870.7M
$840.9M
Q3 24
$870.2M
$667.7M
Q2 24
$841.4M
$704.2M
Q1 24
$834.4M
$762.2M
Total Assets
TR
TR
ZLAB
ZLAB
Q4 25
$1.3B
$1.2B
Q3 25
$1.2B
$1.2B
Q2 25
$1.2B
$1.2B
Q1 25
$1.1B
$1.2B
Q4 24
$1.1B
$1.2B
Q3 24
$1.1B
$985.3M
Q2 24
$1.1B
$987.4M
Q1 24
$1.1B
$988.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
TR
TR
ZLAB
ZLAB
Operating Cash FlowLast quarter
$73.3M
$-26.0M
Free Cash FlowOCF − Capex
$61.0M
$-26.7M
FCF MarginFCF / Revenue
31.1%
-21.0%
Capex IntensityCapex / Revenue
6.3%
0.5%
Cash ConversionOCF / Net Profit
2.55×
TTM Free Cash FlowTrailing 4 quarters
$96.4M
$-158.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
TR
TR
ZLAB
ZLAB
Q4 25
$73.3M
$-26.0M
Q3 25
$62.2M
$-32.0M
Q2 25
$-8.5M
$-31.0M
Q1 25
$3.6M
$-61.7M
Q4 24
$68.8M
$-55.8M
Q3 24
$61.3M
$-26.8M
Q2 24
$-12.6M
$-42.2M
Q1 24
$21.4M
$-90.1M
Free Cash Flow
TR
TR
ZLAB
ZLAB
Q4 25
$61.0M
$-26.7M
Q3 25
$50.7M
$-35.0M
Q2 25
$-16.0M
$-33.9M
Q1 25
$750.0K
$-63.2M
Q4 24
$64.7M
$-58.4M
Q3 24
$55.8M
$-28.2M
Q2 24
$-16.6M
$-42.9M
Q1 24
$16.9M
$-91.1M
FCF Margin
TR
TR
ZLAB
ZLAB
Q4 25
31.1%
-21.0%
Q3 25
21.8%
-30.4%
Q2 25
-10.3%
-31.1%
Q1 25
0.5%
-59.9%
Q4 24
33.5%
-53.8%
Q3 24
24.7%
-27.7%
Q2 24
-11.0%
-42.9%
Q1 24
11.0%
-104.5%
Capex Intensity
TR
TR
ZLAB
ZLAB
Q4 25
6.3%
0.5%
Q3 25
5.0%
2.6%
Q2 25
4.8%
2.6%
Q1 25
1.9%
1.5%
Q4 24
2.1%
2.4%
Q3 24
2.4%
1.3%
Q2 24
2.6%
0.7%
Q1 24
2.9%
1.1%
Cash Conversion
TR
TR
ZLAB
ZLAB
Q4 25
2.55×
Q3 25
1.74×
Q2 25
-0.49×
Q1 25
0.20×
Q4 24
3.06×
Q3 24
1.87×
Q2 24
-0.81×
Q1 24
1.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

TR
TR

Products$194.3M99%
Rental And Royalty$1.9M1%

ZLAB
ZLAB

Zejula$56.0M44%
Other$21.9M17%
Nuzyra$16.0M13%
Optune$11.9M9%
XACDURO$10.7M8%
Qinlock$9.7M8%
AUGTYRO$836.0K1%

Related Comparisons